Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

NCT01152593 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

400

Enrollment

OTHER_GOV

Sponsor class

Conditions

Surgical Wound Infection
Cesarean Section
Staphylococcus Aureus

Interventions

DRUG: Mupirocin

Sponsor

Hillel Yaffe Medical Center